Monolaurin is the monoglyceride of lauric acid (C12), found naturally in breast milk and coconut oil. It dissolves the lipid membranes of enveloped viruses (herpes, influenza, HIV, CMV) and bacteria (Staphylococcus, Streptococcus, H. pylori) by integrating into and disrupting their lipid bilayer. Our research shows strong in vitro evidence against a remarkably broad spectrum of pathogens, but LIMITED human clinical data. The most compelling finding: monolaurin was 5,000x more bactericidal than lauric acid against S. aureus in vitro, suggesting the monoglyceride form is essential. It's one of breast milk's primary antimicrobial defenses in infants.
Monolaurin integrates into microbial lipid bilayer membranes due to its amphiphilic structure (hydrophilic glycerol head + lipophilic lauric acid tail). In enveloped viruses, this dissolves the viral envelope, preventing receptor binding and cell entry — essentially "popping" the virus. In bacteria, monolaurin: (1) disrupts cell membrane integrity, causing leakage of cellular contents; (2) interferes with signal transduction (blocks quorum sensing — the bacterial communication system that coordinates biofilm formation and virulence); (3) inhibits bacterial exotoxin production. Importantly, monolaurin does NOT affect non-enveloped viruses (norovirus, adenovirus) or bacteria with unusual cell wall structures.
No critical interactions identified.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.